CymaBay Therapeutics Inc (DELISTED) (CBAY:DL)
32.48
0.00 (0.00%)
USD |
NASDAQ |
Mar 25, 16:00
CymaBay Therapeutics Accounts Payable (Quarterly): 3.828M for Dec. 31, 2023
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 3.828M |
September 30, 2023 | 2.731M |
June 30, 2023 | 4.589M |
March 31, 2023 | 1.633M |
December 31, 2022 | 1.096M |
September 30, 2022 | 0.479M |
June 30, 2022 | 0.866M |
March 31, 2022 | 0.199M |
December 31, 2021 | 2.728M |
September 30, 2021 | 0.764M |
June 30, 2021 | 1.05M |
March 31, 2021 | 1.606M |
December 31, 2020 | 0.231M |
September 30, 2020 | 0.947M |
June 30, 2020 | 0.476M |
March 31, 2020 | 1.213M |
December 31, 2019 | 2.503M |
September 30, 2019 | 1.494M |
June 30, 2019 | 2.882M |
March 31, 2019 | 2.41M |
December 31, 2018 | 1.973M |
Date | Value |
---|---|
September 30, 2018 | 1.629M |
June 30, 2018 | 1.336M |
March 31, 2018 | 2.038M |
December 31, 2017 | 1.311M |
September 30, 2017 | 1.235M |
June 30, 2017 | 1.101M |
March 31, 2017 | 1.096M |
December 31, 2016 | 0.899M |
September 30, 2016 | 0.935M |
June 30, 2016 | 1.272M |
March 31, 2016 | 1.777M |
December 31, 2015 | 1.008M |
September 30, 2015 | 0.707M |
June 30, 2015 | 1.721M |
March 31, 2015 | 1.527M |
December 31, 2014 | 2.085M |
September 30, 2014 | 1.047M |
June 30, 2014 | 1.262M |
March 31, 2014 | 1.069M |
December 31, 2013 | 0.697M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
0.199M
Minimum
Mar 2022
4.589M
Maximum
Jun 2023
1.648M
Average
1.213M
Median
Mar 2020
Accounts Payable (Quarterly) Benchmarks
Gilead Sciences Inc | 550.00M |
Assure Holdings Corp | 6.84M |
Societal CDMO Inc (DELISTED) | 1.312M |
AN2 Therapeutics Inc | 2.676M |
Madrigal Pharmaceuticals Inc | 28.04M |